Takeda Pharmaceutical Company Limited

TSE:4502 Voorraadrapport

Marktkapitalisatie: JP¥6.5t

Takeda Pharmaceutical Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Takeda Pharmaceutical heeft een totaal eigen vermogen van ¥6,921.6B en een totale schuld van ¥5,051.2B, wat de schuld-eigenvermogensverhouding op 73% brengt. De totale activa en totale passiva bedragen respectievelijk ¥14,573.0B en ¥7,651.4B. De EBIT Takeda Pharmaceutical is ¥653.6B waardoor de rentedekking 6.7 is. Het heeft contanten en kortetermijnbeleggingen van ¥859.0B.

Belangrijke informatie

73.0%

Verhouding schuld/eigen vermogen

JP¥5.05t

Schuld

Rente dekkingsratio6.7x
ContantJP¥859.02b
AandelenJP¥6.92t
Totaal verplichtingenJP¥7.65t
Totaal activaJP¥14.57t

Recente financiële gezondheidsupdates

Recent updates

Results: Takeda Pharmaceutical Company Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 04
Results: Takeda Pharmaceutical Company Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Sep 24
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E

Sep 20
Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Aug 08
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 02
Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Jul 25
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Jul 11
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Jun 30
Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Jun 11
Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

May 21
Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

May 12
Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Mar 28
Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Mar 13
Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Feb 26
Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥3,054.0B ) 4502 } overtreffen de korte termijn passiva ( ¥2,387.2B ).

Langlopende schulden: De kortetermijnactiva van 4502 ( ¥3,054.0B ) dekken de langetermijnschulden ( ¥5,264.2B ) niet.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 60.6% ) 4502 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 4502 is de afgelopen 5 jaar gedaald van 103.2% naar 73%.

Schuldendekking: De schuld van 4502 wordt niet goed gedekt door de operationele kasstroom ( 17.3% ).

Rentedekking: De rentebetalingen op de schuld van 4502 worden goed gedekt door EBIT ( 6.7 x dekking).


Balans


Ontdek gezonde bedrijven